HOSPITAL UNIVERSITARIO RUBER
Fachbereich
Hospital de la Santa Creu i Sant Pau
Barcelona, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital de la Santa Creu i Sant Pau (8)
2021
-
Environmental exposure during pregnancy: Influence on prenatal development and early life: A comprehensive review
Fetal Diagnosis and Therapy, Vol. 48, Núm. 4, pp. 245-257
-
Evolution of angiogenic factors in pregnant patients with breast cancer treated with chemotherapy
Cancers, Vol. 13, Núm. 4, pp. 1-12
2020
-
The evolving microbiome from pregnancy to early infancy: A comprehensive review
Nutrients, Vol. 12, Núm. 1
2018
-
Early evolution of BRAFV600 status in the blood of melanoma patients correlates with clinical outcome and identifies patients refractory to therapy
Melanoma Research, Vol. 28, Núm. 3, pp. 195-203
-
Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel
Clinical Cancer Research, Vol. 24, Núm. 23, pp. 5820-5829
2017
-
A definition for aggressive disease in patients with HER-2 negative metastatic breast cancer: an expert consensus of the Spanish Society of Medical Oncology (SEOM)
Clinical and Translational Oncology, Vol. 19, Núm. 5, pp. 616-624
-
Efficacy of neoadjuvant carboplatin plus docetaxel in triple-negative breast cancer: Combined analysis of two cohorts
Clinical Cancer Research, Vol. 23, Núm. 3, pp. 649-657
2009
-
Nonpegylated liposomal doxorubicin (TLC-D99), Paclitaxel, and Trastuzumab in HER-2-overexpressing breast cancer: A multicenter phase l/ll study
Clinical Cancer Research, Vol. 15, Núm. 1, pp. 307-314